NYMX logo

Nymox Pharmaceutical (NYMX) Gross Margin

Annual Gross Margin

N/A

31 December 2022

NYMX Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Gross Margin

N/A

31 March 2023

NYMX Quarterly Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NYMX Gross Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

NYMX Gross Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time

Nymox Pharmaceutical Gross Margin History

DateAnnualQuarterly
Dec 2020
20.00%(-60.0%)
-
Mar 2020
-
20.00%(-72.6%)
Dec 2019
50.00%(-7.1%)
73.08%(+23.9%)
Sept 2019
-
58.97%(-9.3%)
June 2019
-
65.00%(+1852.0%)
Mar 2019
-
3.33%(-106.3%)
Dec 2018
53.85%(+60.8%)
-52.63%(-240.3%)
Sept 2018
-
37.50%(-48.4%)
June 2018
-
72.73%(+18.9%)
Mar 2018
-
61.18%(+7.1%)
Dec 2017
33.48%(-14.3%)
57.14%(-985.9%)
Sept 2017
-
-6.45%(-96.8%)
June 2017
-
-200.00%(-572.7%)
Mar 2017
-
42.31%(+243.1%)
Dec 2016
39.08%(-58.5%)
12.33%(-5.9%)
Sept 2016
-
13.10%(-81.9%)
June 2016
-
72.38%(-425.4%)
Mar 2016
-
-22.24%(-194.0%)
Dec 2015
94.21%(+0.1%)
23.67%(-31.2%)
Sept 2015
-
34.39%(-11.1%)
June 2015
-
38.70%(-60.7%)
Mar 2015
-
98.55%(+1.8%)
Dec 2014
94.11%(+10.0%)
96.84%(+3.2%)
Sept 2014
-
93.83%(+0.3%)
June 2014
-
93.59%(+1.5%)
Mar 2014
-
92.21%(+21.6%)
Dec 2013
85.53%(-6.8%)
75.84%(-18.9%)
Sept 2013
-
93.51%(+12.9%)
June 2013
-
82.80%(-10.0%)
Mar 2013
-
92.01%(-1.4%)
Dec 2012
91.74%(+1.2%)
93.36%(+1.2%)
Sept 2012
-
92.26%(+2.8%)
June 2012
-
89.76%(-1.9%)
Mar 2012
-
91.53%(-0.2%)
Dec 2011
90.69%(+67.4%)
91.68%(+5.6%)
Sept 2011
-
86.85%(-9.5%)
June 2011
-
95.92%(+8.4%)
Mar 2011
-
88.49%(+16.3%)
Dec 2010
54.16%
76.12%(-225.8%)
Sept 2010
-
-60.52%(-576.9%)
June 2010
-
12.69%(-77.5%)
DateAnnualQuarterly
Mar 2010
-
56.37%(+27.2%)
Dec 2009
40.84%(+5.3%)
44.31%(-28.7%)
Sept 2009
-
62.11%(+57.5%)
June 2009
-
39.44%(+96.5%)
Mar 2009
-
20.07%(-64.4%)
Dec 2008
38.77%(-12.6%)
56.30%(+1250.1%)
Sept 2008
-
4.17%(-91.2%)
June 2008
-
47.49%(+32.4%)
Mar 2008
-
35.87%(-31.1%)
Dec 2007
44.36%(-2.5%)
52.03%(+112.4%)
Sept 2007
-
24.50%(-48.3%)
June 2007
-
47.35%(+5.4%)
Mar 2007
-
44.94%(+18.4%)
Dec 2006
45.49%(-11.4%)
37.97%(-20.4%)
Sept 2006
-
47.68%(-30.6%)
June 2006
-
68.72%(+248.1%)
Mar 2006
-
19.74%(-48.6%)
Dec 2005
51.36%(+21.2%)
38.43%(-34.0%)
Sept 2005
-
58.21%(+7.5%)
June 2005
-
54.14%(-1.5%)
Mar 2005
-
54.97%(-23.9%)
Dec 2004
42.36%(+10.6%)
72.20%(+175.0%)
Sept 2004
-
26.25%(-35.4%)
June 2004
-
40.64%(+23.8%)
Mar 2004
-
32.82%(-14.2%)
Dec 2003
38.31%(-4.5%)
38.27%(+13.0%)
Sept 2003
-
33.87%(-23.9%)
June 2003
-
44.50%(+38.2%)
Mar 2003
-
32.19%(-352.7%)
Dec 2002
40.11%(-8.7%)
-12.74%(-129.0%)
Sept 2002
-
43.91%(+3.2%)
June 2002
-
42.53%(-37.9%)
Mar 2002
-
68.54%(-42.4%)
Dec 2001
43.94%(-1.3%)
119.08%(+44.8%)
Sept 2001
-
82.21%(+11.1%)
June 2001
-
73.97%(+12.6%)
Mar 2001
-
65.68%(+43.4%)
Dec 2000
44.54%(+36.8%)
-
Mar 2000
-
45.79%
Dec 1999
32.57%(-56.1%)
-
Dec 1998
74.17%
-

FAQ

  • What is the all time high annual gross margin for Nymox Pharmaceutical?
  • What is the all time high quarterly gross margin for Nymox Pharmaceutical?

What is the all time high annual gross margin for Nymox Pharmaceutical?

Nymox Pharmaceutical all-time high annual gross profit margin is 94.21%

What is the all time high quarterly gross margin for Nymox Pharmaceutical?

Nymox Pharmaceutical all-time high quarterly gross profit margin is 119.08%